Technological Advancements Boost Global Acute Ischemic Stroke Diagnosis and Treatment Market to Expand at 6.30% CAGR

Acute ischemic stroke can be defined as loss of function in certain parts of brain due to lack or disturbance in the blood supply to the brain. This is usually caused by atherosclerosis plaques blocking blood vessels, narrowing of blood vessels, or blood clots closing off blood supply to or from arteries feeding the brain. Technological advancements in surgical devices coupled with rising prevalence of acute ischemia stroke cases collectively accentuates the global demand of surgical procedures in acute stroke treatment. Similarly, aging population, increased demand for minimally invasive procedures and rise in healthcare spending has triggered the growth of this segment market. However, excessive usage of medication for the treatment of ischemic stroke is anticipated to hinder the global market growth of surgery for acute stroke. The global acute ischemic stroke diagnosis and treatment market was valued at USD 1,225.0 million in 2013 and is expected to grow at a CAGR of 6.3% from 2014 to 2020, to reach an estimated value of USD 1,869.7 million by 2020.

Get Report Sample @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1799

On the basis of type of surgery, the acute ischemic stroke diagnosis and treatment market is segmented into carotid endarterectomy, endovascular mechanical thrombectomy, and angioplasty. While carotid endarterectomy dominated the overall market thanks to short treatment duration, high success rate, and easy availability, this segment is anticipated to lose market share over the next five years owing to high risk of side effects.

Geographically, the global acute ischemic stroke diagnosis and treatment market is divided into Asia Pacific, Europe, North America, and Rest of the World. Primarily driven by the rise in acute ischemic stroke surgeries and availability of technologically advanced medical equipment and devices, North America dominates the worldwide acute ischemic stroke diagnosis and treatment market. The American Heart Association states that every year, an estimated 795,000 patients are diagnosed with stroke in the US, a whopping 85.0% of which are identified as acute ischemic stroke. Seeing that the cost of treating strokes in the country surpasses US$73 bn per year, the North America acute ischemic stroke diagnosis and treatment market is anticipated to retain its lead through 2020.

Europe is the second largest market and is mainly fueled by a large population base of geriatrics. Identified as the most rapidly developing regional market for acute ischemic stroke diagnosis and treatment, Asia Pacific is driven by growing awareness among people, increasing number of global companies turning their focus to developing countries in APAC, expanding pool of potential patients, and rising investments in the region.

View Report @ https://www.transparencymarketresearch.com/acute-ischemic-stroke-treatment.html

Leave a Reply